Immutep (IMMP) Goodwill (2014 - 2021)

Immutep's (IMMP) quarterly Goodwill came in at $7.5 million in Q4 2021, down 5.4% quarter-over-quarter from $8.0 million in Q2 2021.

Analysis

Immutep (IMMP) Goodwill (2014 - 2021) Analysis & Trends

Immutep (IMMP) has reported Goodwill for 3 consecutive years, with $7.5 million the latest figure, recorded in Q4 2021.

For the quarter ending Q4 2021, Goodwill changed N/A year-over-year to $7.5 million; the trailing twelve-month figure through Dec 2021 stood at $7.5 million (changed N/A YoY), and the FY2021 full-year result was $8.0 million, changed N/A from the prior year.
Goodwill declined to $7.5 million in Q4 2021 per IMMP's latest filing, from $8.0 million in the prior quarter.
Across five years, Goodwill topped out at $8.0 million in Q2 2021 and bottomed at $837454.3 in Q4 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	211.73 Bn	197.74 Bn	7.24 Bn
2	Gilead Sciences	180.92 Bn	177.74 Bn	6.22 Bn
3	Vertex Pharmaceuticals	132.16 Bn	124.30 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	82.89 Bn	74.90 Bn	3.93 Bn
5	Argenx Se	61.41 Bn	56.23 Bn	1.37 Bn
6	Moderna	53.99 Bn	48.85 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	34.48 Bn	31.18 Bn	992.69 Mn
8	Biogen	31.15 Bn	29.86 Bn	1.96 Bn
9	Roivant Sciences	30.05 Bn	30.05 Bn	1.16 Mn
10	Immutep	51.68 Mn	51.68 Mn	-

Historic Data

Download Data